Baird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY

Benzinga

2024-10-11

Total revenues increased to US$13.1 million, representing 13.8% year-over-year growthNet income reached US$4.4 million, representing 85.8% year-over-year growth

GUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the "First Half of 2024").

First Half of 2024 Financial Highlights

Total revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.
Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.
Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.
- Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2474109810"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2474109810\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2474109810?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-11 20:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474109810","market":"us","top_or_hot":-1,"title":"Baird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY","media":"Benzinga","content":"<html><body><p><i>Total revenues increased to US$13.1 million, representing 13.8% year-over-year growth</i><i>Net income reached US$4.4 million, representing 85.8% year-over-year growth</i></p><p>GUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- <a href=\"https://laohu8.com/S/BDMD\">Baird Medical Investment Holdings Ltd</a>. (NASDAQ:BDMD) (\"Baird Medical\" or the \"Company\"), a leading microwave ablation (\"MWA\") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the \"First Half of 2024\").</p><p><strong>First Half of 2024 Financial Highlights</strong></p><ul><li>Total revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.</li><li>Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.</li><li>Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.<ul><li>Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.</li></ul></li></ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2024-10-11 20:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><i>Total revenues increased to US$13.1 million, representing 13.8% year-over-year growth</i><i>Net income reached US$4.4 million, representing 85.8% year-over-year growth</i></p><p>GUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- <a href=\"https://laohu8.com/S/BDMD\">Baird Medical Investment Holdings Ltd</a>. (NASDAQ:BDMD) (\"Baird Medical\" or the \"Company\"), a leading microwave ablation (\"MWA\") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the \"First Half of 2024\").</p><p><strong>First Half of 2024 Financial Highlights</strong></p><ul><li>Total revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.</li><li>Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.</li><li>Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.<ul><li>Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.</li></ul></li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BDMD","symbol_name":"百德医疗","start_time":0,"source_url":"https://www.benzinga.com/news/earnings/24/10/41289492/baird-medical-announces-preliminary-h1-revenue-results-of-13-1m-up-13-8-yoy","article_id":"2474109810","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474109810","pubTimestamp":1728648198,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Total revenues increased to US$13.1 million, representing 13.8% year-over-year growthNet income reached US$4.4 million, representing 85.8% year-over-year growthGUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BDMD":"百德医疗"},"translate_title":"Baird Medical公布上半年初步收入为1,310万美元，同比增长13.8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BDMD":0.9},"content_text":"Total revenues increased to US$13.1 million, representing 13.8% year-over-year growthNet income reached US$4.4 million, representing 85.8% year-over-year growthGUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) (\"Baird Medical\" or the \"Company\"), a leading microwave ablation (\"MWA\") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the \"First Half of 2024\").First Half of 2024 Financial HighlightsTotal revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}